General Updates

July 08, 2026 BSE Limited National Stock Exchange of India Limited P. J. Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G Block, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: ISIN: INE837H01020 Dear Sir/Madam, This is to inform you that pursuant to the Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (as amended), the Company has sent a letter to those shareholders whose e-mail addresses are not registered with Company or with any Depository, providing the web-link and QR code from where the Integrated Annual Report for FY 2025-26 including the Notice of 37th Annual General Meeting of the Company, can be accessed. A copy of the letter is enclosed. The above information is also being made available on the website of the Company at https://www.advancedenzymes.com Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal Encl.: As above Advanced enzymes WhereENZYMEisLife ADVANCED ENZYME TECHNOLOGIES LIMITED CIN: L24200MH1989PLC051018 Regd. Office: 5th Floor, 'A' wing, Sun Magnetica, LIC Service Road, Louiswadi, Thane (W) - 400604 Email: investor.grievances@advancedenzymes.com, Website: www.advancedenzymes.com Phone: +91-22-4170 3200, Fax No.: +91-22-2583 5159 Sr No : 1 Date : 08/07/2026 Name Folio No : XXXXXXXXXX Add 1 Add 2 Add 3 City Pincode Sub.: Notice of 37th Annual General Meeting (AGM) of Advanced Enzyme Technologies Limited and Integrated Annual Report for the Financial Year 2025-26. We are pleased to inform you that the 37th Annual General Meeting ('AGM') of the Members of Advanced Enzyme Technologies Limited (‘the Company’) is scheduled to be held on Friday, July 31, 2026, at 10.00 A.M (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM'). As per Regulation 36 (1) (b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations, 2015’), as amended, the web-link, including the exact path, where complete details of the Integrated Annual Report are available is required to be sent to those Member(s) who have not registered their email address(es) either with the Company or with any Depository or MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), Registrar to an issue and Share Transfer Agent (“RTA”) of the Company. Accordingly, this letter is being sent to those Member(s) who have not registered their email address(es) as on the cut-off date as on July 03, 2026. The web-link of the Notice and Integrated Annual Report for the Financial Year 2025-26 are as follows: Website: https://www.advancedenzymes.com Notice: https://www.advancedenzymes.com/investors/announcements-notices/ Exact path of Integrated Annual Report 2025-26: https://www.advancedenzymes.com/investors/annual-report/ Members may scan the following QR Code to access the AGM Notice and Integrated Annual Report for FY26: m rs Bh> ‘f5, Bass AGM Notice Integrated Annual Report FY26 SEBI vide its Master Circular No. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026 and the FAQs released by the SEBI has provided common and simplified norms for processing investor’s service request by RTAs and norms for furnishing PAN, KYC and Nomination details. Further, as per the said SEBI Circular, the Shareholders holding shares in physical form and who have not updated their KYC details (viz., PAN; Choice of Nomination; Contact Details; Mobile Number; Bank Account Details and signature) against their folio on or after April 01, 2024 with RTA, their dividend shall be withheld by the Company and the same shall be immediately released electronically, upon updation of KYC. Pursuant to the Listing Regulations amendment effective November 19, 2025, Dividend, if declared, will only be paid through electronic modes and ‘payable-at-par’ warrants or cheques will not be issued for payment of dividend. The formats for Nomination and Updation of KYC details viz; Forms ISR-1, ISR-2, ISR-3, SH-13, SH-14 and SEBI circulars are available on RTA website as mentioned below: https://www.in.mpms.mufg.com > Resources > Downloads > KYC > Formats for KYC. Should you have any queries, please feel free to contact the Company / RTA at cs@advancedenzymes.com/ rnt.helpdesk@in.mpms.mufg.com Moreover, you are also requested to update your email address at the earliest either through your depository participants for electronic holding or send a communication to aforementioned to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head-Legal